speaker:
Dr. Jiajia Liu is a hematologist at Trillium Health Partners in the Carlo Fidani Peel Regional Centre with a practice focused on hematological cancers including myeloma. Dr. Liu did a malignant Hematology fellowship at the Odette Cancer Centre/Sunnybrook Health Sciences Centre, Hematology subspecialty residence and Internal Medicine residency at the University of Toronto, following medical school at McGill University.
OVERVIEW:
This presentation will review monoclonal gammopathies of clinical significance (MGCS). The presentation will define MGCS, discuss most common presentations, review the workup and treatment of different MGCS, and emphasize the role laboratory medicine plays in the diagnosis and follow-up of MGCS.
LEARNING OBJECTIVES:
At the conclusion of this session, participants will be able to:
1) Define what constitutes a monoclonal gammopathy of clinical significance;
2) Recognize the importance of sensitive laboratory medicine tests for the diagnosis and assessment of response to treatment in MGCS.